Nuveen LLC Purchases Shares of 149,431 Integer Holdings Corporation $ITGR

Key Points

• Nuveen LLC has acquired 149,431 shares of Integer Holdings Corporation, investing approximately $17.6 million, representing 0.43% of the company's stock as of the latest SEC filing.
• Various institutional investors, including Congress Asset Management Co. and Bamco Inc. NY, have increased their stakes in Integer, reflecting a positive sentiment as 99.29% of the stock is owned by such entities.
• Integer recently reported quarterly earnings of $1.55 per share, slightly missing analyst estimates, but revenue increased by 11.4% year-over-year, leading to an expected earnings per share of $6.01 for the current year.

Nuveen LLC bought a new position in Integer Holdings Corporation (NYSE:ITGR - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 149,431 shares of the medical equipment provider's stock, valued at approximately $17,634,000. Nuveen LLC owned about 0.43% of Integer as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently modified their holdings of the business. TD Private Client Wealth LLC lifted its holdings in shares of Integer by 5.8% during the first quarter. TD Private Client Wealth LLC now owns 1,524 shares of the medical equipment provider's stock worth $180,000 after buying an additional 83 shares during the last quarter. Xponance Inc. lifted its holdings in shares of Integer by 5.1% during the first quarter. Xponance Inc. now owns 2,518 shares of the medical equipment provider's stock worth $297,000 after buying an additional 122 shares during the last quarter. Bessemer Group Inc. lifted its holdings in shares of Integer by 73.1% during the first quarter. Bessemer Group Inc. now owns 296 shares of the medical equipment provider's stock worth $35,000 after buying an additional 125 shares during the last quarter. Emerald Mutual Fund Advisers Trust lifted its holdings in shares of Integer by 0.8% during the fourth quarter. Emerald Mutual Fund Advisers Trust now owns 19,867 shares of the medical equipment provider's stock worth $2,633,000 after buying an additional 152 shares during the last quarter. Finally, Nisa Investment Advisors LLC lifted its holdings in shares of Integer by 1.0% during the first quarter. Nisa Investment Advisors LLC now owns 20,450 shares of the medical equipment provider's stock worth $2,413,000 after buying an additional 197 shares during the last quarter. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Integer news, Director Martin C. Maxwell sold 8,720 shares of the company's stock in a transaction on Thursday, June 5th. The stock was sold at an average price of $120.56, for a total value of $1,051,283.20. Following the sale, the director directly owned 22,170 shares in the company, valued at $2,672,815.20. This represents a 28.23% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Donald J. Spence sold 14,739 shares of the company's stock in a transaction on Wednesday, June 4th. The shares were sold at an average price of $120.38, for a total value of $1,774,280.82. Following the completion of the sale, the director owned 18,781 shares in the company, valued at $2,260,856.78. This trade represents a 43.97% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 2.16% of the company's stock.

Analyst Ratings Changes

A number of research analysts have recently commented on ITGR shares. Wall Street Zen upgraded Integer from a "sell" rating to a "hold" rating in a report on Monday, May 19th. Wells Fargo & Company cut their price target on Integer from $152.00 to $132.00 and set an "overweight" rating for the company in a report on Friday, July 25th. Raymond James Financial cut their price target on Integer from $150.00 to $143.00 and set an "outperform" rating for the company in a report on Friday, July 25th. Truist Financial cut their price target on Integer from $145.00 to $137.00 and set a "buy" rating for the company in a report on Friday, July 25th. Finally, Citigroup upgraded Integer from a "hold" rating to a "strong-buy" rating and upped their price target for the stock from $133.00 to $140.00 in a report on Thursday, May 22nd. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has assigned a Hold rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Buy" and an average target price of $140.25.

Integer Stock Performance

Shares of ITGR traded down $1.5990 on Monday, reaching $108.9810. 256,908 shares of the stock traded hands, compared to its average volume of 355,626. The firm has a market cap of $3.82 billion, a price-to-earnings ratio of 48.01, a P/E/G ratio of 0.87 and a beta of 1.02. The company has a debt-to-equity ratio of 0.72, a current ratio of 3.41 and a quick ratio of 2.18. Integer Holdings Corporation has a 12 month low of $104.93 and a 12 month high of $146.36. The stock's 50-day moving average price is $113.57 and its 200-day moving average price is $118.67.

Integer (NYSE:ITGR - Get Free Report) last released its quarterly earnings data on Thursday, July 24th. The medical equipment provider reported $1.55 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.57 by ($0.02). The firm had revenue of $476.00 million for the quarter, compared to the consensus estimate of $464.37 million. Integer had a net margin of 4.61% and a return on equity of 12.27%. The business's revenue for the quarter was up 11.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.30 earnings per share. Integer has set its FY 2025 guidance at 6.250-6.510 EPS. Equities analysts forecast that Integer Holdings Corporation will post 6.01 EPS for the current fiscal year.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.